Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures | NEJM
Perspective from The New England Journal of Medicine — Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures
Perspective from The New England Journal of Medicine — Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures
Current understanding of the heterogeneity of post-acute COVID-19 syndrome (PACS) is limited. Examining the fecal microbiome in subjects with PACS, Su et al. uncover an association…
Our findings suggest that residual SARS-CoV-2 can persist in patients who have recovered from mild COVID-19 and that there is a significant association between viral…
Respiratory virus infections in humans cause a broad-spectrum of diseases that result in substantial morbidity and mortality annually worldwide. To…
Making healthy dietary choices is essential for keeping weight within a normal range. Yet many people struggle with dietary self-control despite go…
There is a lot less Covid data around now, but what there is shows that levels of Covid remain low in the UK. That said,…
This cohort study evaluates the risk of postoperative respiratory complications among patients with diabetes undergoing surgery who had vs those who had not a prescription…
Nature Microbiology – Targeted accurate RNA consensus sequencing enables study of de novo errors caused by RNA-dependent RNA polymerases and provides deeper insights into how…
BACKGROUND: The risk factor (RF) burden, clinical course, and long-term outcome among patients with atrial fibrillation (AF) aged <65 years is unclear. METHODS: Adult (n=67 221;…
Original Article from The New England Journal of Medicine — Microplastics and Nanoplastics in Atheromas and Cardiovascular Events